Many cellular mRNAs contain the modified base m 6 A, and recent studies have suggested that various stimuli can lead to changes in m 6 A. the most common method to map m 6 A and to predict changes in m 6 A between conditions is methylated RNA immunoprecipitation sequencing (MeRIP-seq), through which methylated regions are detected as peaks in transcript coverage from immunoprecipitated RNA relative to input RNA. Here, we generated replicate controls and reanalyzed published MeRIP-seq data to estimate reproducibility across experiments. We found that m 6 A peak overlap in mRNAs varies from ~30 to 60% between studies, even in the same cell type. We then assessed statistical methods to detect changes in m 6 A peaks as distinct from changes in gene expression. However, from these published data sets, we detected few changes under most conditions and were unable to detect consistent changes across studies of similar stimuli. Overall, our work identifies limits to MeRIP-seq reproducibility in the detection both of peaks and of peak changes and proposes improved approaches for analysis of peak changes. Methylation at the N6 position in adenosine (m 6 A) is the most common internal modification in eukaryotic mRNA. A methyltransferase complex composed of METTL3, METTL14, WTAP, VIRMA, and other cofactors catalyzes methylation at DRACH/DRAC motifs, primarily in the last exon 1,2. Most m 6 A methylation occurs during transcription 3. The modification then affects mRNA metabolism through recognition by RNA-binding proteins that regulate processes including translation and mRNA degradation 4-9. However, whether m 6 A is lost and gained in response to various cellular changes remains contentious 3,10-15. To assess the evidence for proposed dynamic changes in m 6 A, a reliable and reproducible method to detect changes in methylation as distinct from changes in gene expression is necessary. The first and most widely-used method to enable transcriptome-wide studies of m 6 A, MeRIP-seq or m 6 A-seq, involves the immunoprecipitation of m 6 A-modified RNA fragments followed by peak detection through comparison to background gene coverage 16,17. A second method was developed in 2015, miCLIP or m 6 A-CLIP, which involves crosslinking at the site of antibody binding to induce mutations during reverse transcription for single-nucleotide detection of methylated bases 2,18. MeRIP-seq is still more often used than miCLIP, despite less precise localization of m 6 A to peak regions of approximately 50-200 base pairs that can contain multiple DRAC motifs, since it follows a simpler protocol, requires less starting material, and generally produces higher coverage of more transcripts. Antibodies for m 6 A can also detect a second base modification, N 6 ,2′-O-dimethyladenosine (m 6 A m), found at a lower abundance than m 6 A and located at the 5′ ends of select transcripts 15,18. We thus refer to the base modifications detected through MeRIP-seq collectively as m 6 A (m) , although most are likely m 6 A. As of late 2018, over fifty studies used M...